QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio ...

Devonian is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs ...

The Devonian Period, spanning approximately 419–359 million years ago, represents a pivotal phase in South America’s deep-time history. Fossiliferous formations across the continent—particularly ...

Luc Grégoire, current Director of Devonian, appointed as President and CEO, brings 30 years of financial capital markets, strategic and operational leadership David Baker transitions from board ...

QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation, focused on developing a ...

Devonian Health Group Announces the Formation of a Scientific Advisory Board with Mandate to Assist in the Development of Cannabinoïds-Based Pharmaceutical Products. Devonian Health Group Inc.

QUEBEC CITY — Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation focused on developing a unique portfolio of botanical ...

"Our year-end results reflect a company that is financially disciplined, debt-free, and strategically positioned for the next phase of value creation. With this strong foundation, we are intensifying ...

The Devonian is a geologic period of the Paleozoic Era spanning approximately 419 to 359 million years ago, defined chronostratigraphically by its base at the first appearance of the conodont Ireviken ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical pharmaceutical corporation focused on ...

QUEBEC — Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation focused on developing a unique portfolio of botanical ...